LivaNova (LIVN) EPS (Diluted) Growth (1y) (2015 - 2026)
LivaNova (LIVN) EPS (Diluted) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 13.96% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 288.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 288.92% |
| Mar 31, 2026 | 106.88% |
| Dec 31, 2025 | -44.66% |
| Sep 30, 2025 | -19.43% |
| Jun 30, 2025 | 65.69% |
| Mar 31, 2025 | -674.91% |
| Dec 31, 2024 | 239.45% |
| Sep 30, 2024 | 546.84% |
| Jun 30, 2024 | 1,267.54% |
| Mar 31, 2024 | -665.54% |
| Dec 31, 2023 | 854.60% |
| Sep 30, 2023 | 93.27% |
| Jun 30, 2023 | -92.81% |
| Mar 31, 2023 | 145.21% |
| Dec 31, 2020 | -364.98% |
| Dec 31, 2019 | 118.35% |
| Jun 30, 2019 | 104.07% |
| Dec 31, 2018 | 98.73% |
| Sep 30, 2018 | -210.69% |
| Jun 30, 2018 | -340.15% |